Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Paul Berns Insider Profile

4 Followers

Paul Berns, Executive Chair of the Board, Director at Neumora Therapeutics, Inc., holds 15.06M shares in Kardigan, Inc. (Ticker: KARD), holds 7.79M shares in Neumora Therapeutics, Inc. (Ticker: NMRA), holds 0.00 shares in Metsera, Inc. (Ticker: MTSR). Most recently, Paul Berns Bought ― shares of Kardigan, Inc. on Jun 24, 2026 for an estimated value of $20.00M.

Paul Berns's Trading History

KARDKardigan, Inc.		Jun 24, 2026Director, Ten Percent OwnerInformative Buy20.00M$212.84M
NMRANeumora Therapeutics, Inc.		Feb 19, 2026Executive Chair of the Board, DirectorInformative Sell34.37K$2.86M
MTSRMetsera, Inc.		Nov 13, 2025―Uninformative Sell―$0.00
EQRXEQRx, Inc.		Nov 09, 2023―Uninformative Sell―$0.00
JAZZJazz Pharmaceuticals		Aug 09, 2021DirectorInformative Sell223.30K$1.79M
UNBXUnity Biotechnology		May 07, 2018―Uninformative Buy―$182.62
~ANACAnacor Pharmaceuticals		Jun 24, 2016―Uninformative Sell22.96M$26.53M
CLRBCellectar Biosciences		Apr 21, 2016DirectorInformative Buy248.83K$0.00
XNPTXenoPort		May 21, 2015―Uninformative Buy―$70.70K
YARWYarrow Bioscience		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Paul Berns insider profile FAQ

What is the percentage of profitable transactions made by Paul Berns?
The percentage of profitable transactions made by Paul Berns is 45%.
What is the average return per transaction made by Paul Berns?
The average return per transaction made by Paul Berns is 4.10%.
What stocks does Paul Berns hold?
Paul Berns holds: NMRA, ~ANAC, YARW, UNBX, EQRX, MTSR, KARD, JAZZ, XNPT, CLRB stocks.
What was Paul Berns’s latest transaction?
Paul Berns’s latest transaction was an Informative Buy of $20.00M.
What was Paul Berns's most profitable transaction?
Paul Berns’s most profitable transaction was an Informative Sell of NMRA stock on February 19, 2026. The return on the trade was 89.40%.
What is Paul Berns's role in Neumora Therapeutics, Inc.?
Paul Berns's role in Neumora Therapeutics, Inc. is Executive Chair of the Board, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.